Recruiting Cancer Clinical Trials

AcceleRET-Lung / BO42864 (formerly BLU-667-2303)

A Randomized, Open-Label, Phase 3 Study of Pralsetinib Versus Standard of Care Plt-based Chemotherapy for First Line RET Fusion-positive, Metastatic Non-Small Cell Lung Cancer
Description:
Study Phase: Phase 3
Principal Investigator: Dr Sinead Cuffe
Further information

ETOP Adeppt

A multicentre, single-arm phase II trial of adagrasib in patients with KRAS G12C-mutant NSCLC, including the elderly (≥70 years) or patients with poor performance status.
Description:
Study Phase: Phase 3
Principal Investigator: Dr Sinead Cuffe
Further information

Neo-Coast

A Phase 2 Open-label, Multicenter, Randomized, Study of Neoadjuvant and Adjuvant Treatment in Subjects with Resectable, Early-stage (II to IIIA) Non-small Cell Lung Cancer (NeoCOAST-2)
Description:
Study Phase: Phase 2
Principal Investigator: Dr Sinead Cuffe
Further information